Simple Summary Liver cancer is a major health problem worldwide, and its early detection
and management are imperative for improving patient outcomes. Biomarkers have great …

Hepatocellular carcinoma (HCC) is a significant cause of morbidity and mortality worldwide.
Despite significant advancements in detection and treatment of HCC, its management …

Liver cancers are the fourth leading cause of cancer-related mortality worldwide. In the past
decade, breakthroughs in the field of artificial intelligence (AI) have inspired development of …

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver with high
morbidity and mortality rates worldwide. Since 1963, when alpha-fetoprotein (AFP) was …

Despite recent improvements in therapeutic interventions, hepatocellular carcinoma is still
associated with a poor prognosis in patients with an advanced disease at diagnosis …

BACKGROUND Prediction of survival after the treatment of hepatocellular carcinoma (HCC)
has been widely investigated, yet remains inadequate. The application of artificial …

Although artificial intelligence (AI) was initially developed many years ago, it has
experienced spectacular advances over the last 10 years for application in the field of …

Hepatocellular carcinoma (HCC) currently represents the fifth most common malignancy and
the third-leading cause of cancer-related death worldwide, with incidence and mortality rates …

Hepatocellular carcinoma (HCC) is one of the most aggressive and truculent types of
cancer. Early detection of HCC is a massive concern that can boost the overall survival rates …

Liver cancer is one of the most common malignancies, with severe morbidity and mortality.
While considerable progress has been made in liver cancer treatment, the 5-year overall …